INSP - Inspire Medical Systems, Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 7.50B
Enterprise value 7.05B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.71
Price/book (mrq)15.11
Enterprise value/revenue 15.12
Enterprise value/EBITDA -169.00

Trading information

Stock price history

Beta (5Y monthly) 1.44
52-week change 366.43%
S&P500 52-week change 31.77%
52-week high 3314.36
52-week low 3157.04
50-day moving average 3265.46
200-day moving average 3234.08

Share statistics

Avg vol (3-month) 3365.58k
Avg vol (10-day) 3388.93k
Shares outstanding 529.17M
Implied shares outstanding 6N/A
Float 828.72M
% held by insiders 11.55%
% held by institutions 198.48%
Shares short (14 May 2023) 41.18M
Short ratio (14 May 2023) 43.15
Short % of float (14 May 2023) 44.57%
Short % of shares outstanding (14 May 2023) 44.03%
Shares short (prior month 13 Apr 2023) 41.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin -9.35%
Operating margin (ttm)-10.94%

Management effectiveness

Return on assets (ttm)-7.40%
Return on equity (ttm)-11.95%

Income statement

Revenue (ttm)466.37M
Revenue per share (ttm)16.38
Quarterly revenue growth (yoy)84.30%
Gross profit (ttm)341.74M
EBITDA -48.94M
Net income avi to common (ttm)-43.61M
Diluted EPS (ttm)-1.50
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)452.06M
Total cash per share (mrq)15.5
Total debt (mrq)8.55M
Total debt/equity (mrq)1.70
Current ratio (mrq)8.91
Book value per share (mrq)17.30

Cash flow statement

Operating cash flow (ttm)22.97M
Levered free cash flow (ttm)24.58M